Testosterone deficiency deserves the same attention we give to any other age-related health concern. Providers can play a big role by starting the conversation when a patient brings up things like low energy, mood changes or reduced sex drive.
Arrhythmia Research Technology Inc. (NYSE:HRT) bought out the remaining shares of Prince Edward Island, Canada-based RMDDx Corp. in a stock and options swap. The Fitchburg, Mass.-based cardiac support technology maker carried out the deal through RMDDx’s U.S.-based subsidiary RMDDxUSA Corp., according to a press release. ART issued 115,033 shares of its unregistered common stock and […]
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.